Eton Pharmaceuticals (ETON) Inventory (2019 - 2026)

Eton Pharmaceuticals has disclosed Inventory across 8 years of filings, most recently posting $10.1 million for Q2 2026.

• In Q2 2026, Inventory fell 57.37% year-over-year to $10.1 million; the TTM figure through Jun 2026 stood at $10.1 million (down 57.37% YoY), while the FY2025 annual figure was $15.4 million, up 1.23% from the prior year.
• Inventory came in at $10.1 million for Q2 2026 at Eton Pharmaceuticals, down from $15.4 million in the prior quarter.
• In the past five years, Inventory ranged from a high of $23.8 million in Q2 2025 to a low of $437000.0 in Q1 2023.
• Average Inventory over 5 years is $6.3 million, with a median of $1.9 million recorded in 2024.
• Year-over-year, Inventory sank 62.17% in 2022 and soared 1572.01% in 2024.
• Over 5 years, Inventory stood at $557000.0 in 2022, then soared by 63.55% to $911000.0 in 2023, then soared by 1572.01% to $15.2 million in 2024, then rose by 1.23% to $15.4 million in 2025, then sank by 34.22% to $10.1 million in 2026.
• Per Business Quant data, the three most recent Inventory figures were $10.1 million in Q2 2026, $15.4 million in Q4 2025, and $16.9 million in Q3 2025.